Developer docs
API playgroundTry for free, no card

Search company profiles

Cosm Medical

Full company profile

uuid00021ar

Namestring
Cosm Medical
Legal namestring
Cosm Medical Corp.
Websiteurl
cosm.care
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Cosm Medical Corp. is a Toronto-based medical technology company founded in 2021 that has developed Gynethotics, described as the world's first personalized pessaries for pelvic floor disorders including pelvic organ prolapse and urinary/fecal incontinence. The platform combines 3D transperineal ultrasound imaging, AI-driven anatomical measurement and design generation, and 3D printing of biocompatible silicone devices to produce made-to-measure pessaries that the company positions as an improvement over standard off-the-shelf options, which carry reported 30% fitting failure, 50% one-year dropout, and 56% complication rates. The product portfolio spans the Gynethotics Pessary, the V-Caliper handheld measurement tool, a Clinic App for clinician workflow (design, ordering, patient management), and a Patient App for education and progress tracking. A second product line, Gynethotics Recovery, is in development through licensing agreements with Duke Health and Mayo Clinic for post-surgical pelvic recovery applications.

The company operates a B2B2C go-to-market model, distributing through partner clinics in Canada and expanding into the United States following FDA clearance and a Seed+ financing round in June 2025. Revenue is generated through hardware sales of personalized pessaries (designed-to-order with multi-year device lifecycles) and subscription software access to the Clinic and Patient Apps. Insurance coverage is established with Manulife, Sun Life, Johnson Insurance, and Blue Cross Blue Shield. The company holds granted patents in the United States (two), Canada, and China, plus Health Canada licensing and FDA 510(k) clearance. Strategic clinical partnerships extend across Mount Sinai, Michigan Medicine, Cleveland Clinic, University of Ottawa, Penn Medicine, Northwell Health, and Women's College Hospital, supporting both clinical validation and clinician network development.

Short descriptiontext

Cosm Medical is a Toronto-based medical technology company that develops Gynethotics, the world's first personalized 3D-printed pessaries for pelvic floor disorders, combining AI, 3D ultrasound imaging, and software apps to serve clinicians and women with prolapse or incontinence.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
personalized medical devices, digital gynecology, pelvic floor disorder treatment, 3D printed pessaries, women's health technology
Industry1 code
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Personalized Pelvic Health Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Gynethotics Personalized Pessaries
TypeHardware Sales
Description

Sale of personalized, 3D-printed biocompatible silicone pessaries for pelvic floor disorder treatment. Devices are designed-to-order for individual patients based on clinician measurements and imaging. Designed for usage periods of up to 3 years.

cosm.care
2Digital Gynecology Software Platforms
TypeSubscription Recurring
Description

Software-as-a-Service platforms for clinicians (Clinic App) and patients (Patient App) enabling device design, ordering, patient management, and outcome tracking.

cosm.care
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Gynethotics Pessaries (Personalized)
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed. Insurance coverage available through select providers including Manulife, Sun Life, Johnson Insurance, and Blue Cross Blue Shield.

cosm.care
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Gynethotics
Description

Personalized pessaries for pelvic floor disorders, the world's first made-to-measure gynecological orthotics using AI, medical imaging, and 3D printing.

cosm.care
Core offering1 text field

Cosm Medical designs, manufactures, and sells Gynethotics — the world's first personalized pessaries for pelvic floor disorders (prolapse and incontinence) — made-to-measure via 3D printing of biocompatible silicone based on clinician measurements and AI-assisted medical imaging. The company also provides a Clinic App for clinicians to design, order, and manage devices and patient data, and a Patient App for symptom reporting, education, and progress tracking. Products are Health Canada licensed and FDA cleared and are sold primarily through urogynecology and pelvic health clinics in Canada with U.S. expansion underway.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 30% fitting failure rate with traditional pessaries vs. personalized Gynethotics addressing this gap
+2 more records
Product overview1 text field

Cosm Medical offers a unified digital gynecology platform centered on Gynethotics™ — the world's first personalized pessaries for pelvic floor disorders. The portfolio integrates hardware (3D-printed personalized pessaries, V-Caliper measurement tool) with software (Clinic App and Patient App) to deliver personalized care from assessment through ongoing treatment. The platform uses medical imaging, AI, and 3D printing to create customized devices. A new product line, Gynethotics™ Recovery, extends the platform to post-surgical pelvic care. The ecosystem enables clinicians to measure, design, order, and monitor personalized devices while patients access educational resources and track progress.

Product and service4 records
1Gynethotics Personalized Pessaries
CategoryPersonalized Pelvic Health Devices
Description

The world's first personalized pessaries for treating pelvic floor disorders (prolapse and incontinence), made-to-measure using 3D printing of biocompatible silicone and tailored to each patient's unique anatomy via AI-assisted medical imaging; Health Canada licensed and FDA cleared.

2Clinic App
CategoryClinical Software (SaMD)
Description

Digital gynecology web application for clinicians to design and order personalized Gynethotics pessaries, manage patient data, track outcomes, and support patients through a streamlined workflow.

3Patient App
CategoryPatient Software
Description

Patient-facing digital gynecology application providing educational resources, symptom reporting, and progress tracking to support patients throughout their pelvic care journey.

4V-Caliper
CategoryClinical Measurement Device
Description

A low-cost, easy-to-use handheld measurement tool designed to improve accuracy of clinical assessments during pessary fitting; Health Canada licensed.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

Licensing and collaboration agreement for Gynethotics Recovery, personalized intravaginal devices for post-surgical pelvic recovery following reconstructive surgery. Focuses on product evaluation, clinical validation, and potential commercialization. Cosm Medical licensed IP related to novel device design from Duke Health.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

Licensing and collaboration agreement for Gynethotics Recovery, personalized intravaginal devices for post-surgical pelvic recovery. Collaboration focuses on product evaluation, clinical validation, and commercialization. Mayo Clinic licensed IP related to novel device design.

3Tech4Eva
Strategic tierSupportingTypeGTM or Marketing Partner
Description

Global femtech accelerator program. Cosm Medical joined as a startup member to advance women's health innovation and gain access to industry resources and networking.

cosm.care
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

NGen announced $79.5 million in AI projects including initiatives for healthcare devices. Cosm Medical is one of 16 lead companies in projects spanning advanced materials, semiconductor manufacturing, healthcare devices, and sustainable construction.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical advisor partnership with Dr. Colleen McDermott, Urogynecologist at Mount Sinai Hospital in Toronto.

6Michigan Medicine (Dr. Christopher Hong)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical advisor partnership with Dr. Christopher Hong, Urogynecologist at Michigan Medicine.

cosm.care
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical advisor partnership with Dr. Howard Goldman, Urologist at Cleveland Clinic.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic research partnership with Dr. Linda McLean, Professor and Chair in Women's Health Research at University of Ottawa.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical advisor partnership with Diane Newman, DNP, CRNP, FAAN, BCB-PMD, Co-director for Continence & Pelvic Health at Penn Medicine.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical advisor partnership with Dr. Bilal Chughtai, Chief of Urology at Northwell Health.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Dr. Goli Ameri, Head of Research at Cosm Medical, spoke at Women's College Hospital on transforming women's pelvic health with AI and 3D printing.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CooperSurgical is the dominant incumbent in women's health and pelvic floor devices, including the widely used Milex line of silicone pessaries that Cosm's Gynethotics directly aim to displace. Competes in the same urogynecology channel with established clinician relationships and broad distribution.

TypeBroad incumbent
Description

Medtronic operates in pelvic floor disorders through its sacral neuromodulation (InterStim) and gastroenterology/urology franchises, competing for the same incontinence patients via a different mechanism (neuromodulation vs. mechanical pessary) and acting as a broad incumbent in the broader pelvic health category.

TypeBroad incumbent
Description

Hologic is a large women's health company spanning diagnostics, surgical, and skeletal health products, with overlapping reach into the OB/GYN and urogynecology channels Cosm sells into. Comparable as a broad incumbent that could represent both a competitor and a strategic acquirer.

TypeBroad incumbent
Description

Boston Scientific has a sizable women's health and pelvic floor franchise (including the Solyx and Obtryx sling systems) and competes with Cosm indirectly for the same prolapse and incontinence patients, albeit via a broader surgical-portfolio approach rather than personalized pessaries.

TypeDirect peer
Description

Coloplast is a global leader in ostomy, continence, and pelvic floor products, including pessaries and related women's health devices sold through the same urogynecology and urology channels Cosm targets. Comparable in product category and customer base, with much larger scale and geographic reach.

TypeDirect peer
Description

Caldera Medical develops and markets medical devices for pelvic floor disorders, including mesh and biologic implants for stress urinary incontinence and prolapse. Directly comparable as a focused pelvic-floor device specialist selling to the same urogynecologist customer base.

7Axonics
TypeEmerging player
Description

Axonics develops sacral neuromodulation systems for urge incontinence and overactive bladder, addressing an overlapping patient population to Cosm via an implantable device. Comparable as a focused, growth-stage pelvic-health device company that has scaled commercially and provides a relevant exit/comp benchmark.

TypeEmerging player
Description

Renovia is a women's health startup developing digital therapeutics and connected devices (e.g., leva Pelvic Health System) for pelvic floor disorders. Comparable as a venture-backed, emerging pelvic-floor player pursuing a tech-enabled, non-surgical approach that overlaps Cosm's patient population.

TypeEmerging player
Description

Elvie markets connected pelvic-floor exercise devices (e.g., Elvie Trainer, Perifit) targeting the same pelvic-floor-disorder patient population Cosm addresses, but via a consumer-grade muscle-training modality rather than a personalized medical device. Comparable as a venture-backed women's health/femtech peer.

TypeOthers
Description

Materialise is a global leader in 3D printing for medical devices, including patient-specific implants and surgical guides. Comparable to Cosm as a 3D-printing medical technology company, though Materialise is a much larger contract-manufacturing and software platform rather than a direct pessary competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cosm Medical

Personalized Pelvic Health Medical Devicescosm.care

Cosm Medical is a Toronto-based medical technology company that develops Gynethotics, the world's first personalized 3D-printed pessaries for pelvic floor disorders, combining AI, 3D ultrasound imaging, and software apps to serve clinicians and women with prolapse or incontinence.

What Cosm Medical does

Cosm Medical Corp. is a Toronto-based medical technology company founded in 2021 that has developed Gynethotics, described as the world's first personalized pessaries for pelvic floor disorders including pelvic organ prolapse and urinary/fecal incontinence. The platform combines 3D transperineal ultrasound imaging, AI-driven anatomical measurement and design generation, and 3D printing of biocompatible silicone devices to produce made-to-measure pessaries that the company positions as an improvement over standard off-the-shelf options, which carry reported 30% fitting failure, 50% one-year dropout, and 56% complication rates. The product portfolio spans the Gynethotics Pessary, the V-Caliper handheld measurement tool, a Clinic App for clinician workflow (design, ordering, patient management), and a Patient App for education and progress tracking. A second product line, Gynethotics Recovery, is in development through licensing agreements with Duke Health and Mayo Clinic for post-surgical pelvic recovery applications.

The company operates a B2B2C go-to-market model, distributing through partner clinics in Canada and expanding into the United States following FDA clearance and a Seed+ financing round in June 2025. Revenue is generated through hardware sales of personalized pessaries (designed-to-order with multi-year device lifecycles) and subscription software access to the Clinic and Patient Apps. Insurance coverage is established with Manulife, Sun Life, Johnson Insurance, and Blue Cross Blue Shield. The company holds granted patents in the United States (two), Canada, and China, plus Health Canada licensing and FDA 510(k) clearance. Strategic clinical partnerships extend across Mount Sinai, Michigan Medicine, Cleveland Clinic, University of Ottawa, Penn Medicine, Northwell Health, and Women's College Hospital, supporting both clinical validation and clinician network development.

Cosm Medical firmographics

Firmographics
Name
Cosm Medical
Legal name
Cosm Medical Corp.
Website
https://cosm.care
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Cosm Medical is a Toronto-based medical technology company that develops Gynethotics, the world's first personalized 3D-printed pessaries for pelvic floor disorders, combining AI, 3D ultrasound imaging, and software apps to serve clinicians and women with prolapse or incontinence.
Ownership category
akta.pro rank

Cosm Medical industry classification

Industry
Product category
Personalized Pelvic Health Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Personalized medical devices
  • Digital gynecology
  • Pelvic floor disorder treatment
  • 3D printed pessaries
  • Women's health technology

Where Cosm Medical is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Cosm Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Gynethotics Personalized Pessaries: Sale of personalized, 3D-printed biocompatible silicone pessaries for pelvic floor disorder treatment. Devices are designed-to-order for individual patients based on clinician measurements and imaging. Designed for usage periods of up to 3 years.
  2. Digital Gynecology Software Platforms: Software-as-a-Service platforms for clinicians (Clinic App) and patients (Patient App) enabling device design, ordering, patient management, and outcome tracking.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractGynethotics Pessaries (Personalized)

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Cosm Medical product offering

Product offering

Core offering

Cosm Medical designs, manufactures, and sells Gynethotics — the world's first personalized pessaries for pelvic floor disorders (prolapse and incontinence) — made-to-measure via 3D printing of biocompatible silicone based on clinician measurements and AI-assisted medical imaging. The company also provides a Clinic App for clinicians to design, order, and manage devices and patient data, and a Patient App for symptom reporting, education, and progress tracking. Products are Health Canada licensed and FDA cleared and are sold primarily through urogynecology and pelvic health clinics in Canada with U.S. expansion underway.

Product overview

Cosm Medical offers a unified digital gynecology platform centered on Gynethotics™ — the world's first personalized pessaries for pelvic floor disorders. The portfolio integrates hardware (3D-printed personalized pessaries, V-Caliper measurement tool) with software (Clinic App and Patient App) to deliver personalized care from assessment through ongoing treatment. The platform uses medical imaging, AI, and 3D printing to create customized devices. A new product line, Gynethotics™ Recovery, extends the platform to post-surgical pelvic care. The ecosystem enables clinicians to measure, design, order, and monitor personalized devices while patients access educational resources and track progress.

Differentiator

Problem solved

Functional benefit

Brands

  • Gynethotics: Personalized pessaries for pelvic floor disorders, the world's first made-to-measure gynecological orthotics using AI, medical imaging, and 3D printing.

Products and services

  • Gynethotics Personalized Pessaries The world's first personalized pessaries for treating pelvic floor disorders (prolapse and incontinence), made-to-measure using 3D printing of biocompatible silicone and tailored to each patient's unique anatomy via AI-assisted medical imaging; Health Canada licensed and FDA cleared.
  • Clinic App Digital gynecology web application for clinicians to design and order personalized Gynethotics pessaries, manage patient data, track outcomes, and support patients through a streamlined workflow.
  • Patient App Patient-facing digital gynecology application providing educational resources, symptom reporting, and progress tracking to support patients throughout their pelvic care journey.
  • V-Caliper A low-cost, easy-to-use handheld measurement tool designed to improve accuracy of clinical assessments during pessary fitting; Health Canada licensed.

Quantifiable outcome

  • 30% fitting failure rate with traditional pessaries vs. personalized Gynethotics addressing this gap
  • +2 more outcomes

Companies that use Cosm Medical

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Cosm Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Cosm Medical partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and supporting.

  • Duke HealthcoreStrategic or Co-development Partner · 27 May 2026Licensing and collaboration agreement for Gynethotics Recovery, personalized intravaginal devices for post-surgical pelvic recovery following reconstructive surgery. Focuses on product evaluation, clinical validation, and potential commercialization. Cosm Medical licensed IP related to novel device design from Duke Health.
  • Mayo CliniccoreStrategic or Co-development Partner · 27 May 2026Licensing and collaboration agreement for Gynethotics Recovery, personalized intravaginal devices for post-surgical pelvic recovery. Collaboration focuses on product evaluation, clinical validation, and commercialization. Mayo Clinic licensed IP related to novel device design.
  • Tech4EvasupportingGTM or Marketing PartnerGlobal femtech accelerator program. Cosm Medical joined as a startup member to advance women's health innovation and gain access to industry resources and networking.
  • NGen (Next Generation Manufacturing Canada)supportingStrategic or Co-development PartnerNGen announced $79.5 million in AI projects including initiatives for healthcare devices. Cosm Medical is one of 16 lead companies in projects spanning advanced materials, semiconductor manufacturing, healthcare devices, and sustainable construction.
  • Mount Sinai (Dr. Colleen McDermott)supportingStrategic or Co-development PartnerClinical advisor partnership with Dr. Colleen McDermott, Urogynecologist at Mount Sinai Hospital in Toronto.
  • Michigan Medicine (Dr. Christopher Hong)supportingStrategic or Co-development PartnerClinical advisor partnership with Dr. Christopher Hong, Urogynecologist at Michigan Medicine.
  • Cleveland Clinic (Dr. Howard Goldman)supportingStrategic or Co-development PartnerClinical advisor partnership with Dr. Howard Goldman, Urologist at Cleveland Clinic.
  • University of Ottawa (Dr. Linda McLean)supportingStrategic or Co-development PartnerAcademic research partnership with Dr. Linda McLean, Professor and Chair in Women's Health Research at University of Ottawa.
  • Penn Medicine (Diane Newman)supportingStrategic or Co-development PartnerClinical advisor partnership with Diane Newman, DNP, CRNP, FAAN, BCB-PMD, Co-director for Continence & Pelvic Health at Penn Medicine.
  • Northwell Health (Dr. Bilal Chughtai)supportingStrategic or Co-development PartnerClinical advisor partnership with Dr. Bilal Chughtai, Chief of Urology at Northwell Health.
  • Women's College HospitalsupportingStrategic or Co-development PartnerDr. Goli Ameri, Head of Research at Cosm Medical, spoke at Women's College Hospital on transforming women's pelvic health with AI and 3D printing.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Cosm Medical competitors and assessment

Company assessment

Direct peers

  • CooperSurgical: CooperSurgical is the dominant incumbent in women's health and pelvic floor devices, including the widely used Milex line of silicone pessaries that Cosm's Gynethotics directly aim to displace. Competes in the same urogynecology channel with established clinician relationships and broad distribution.
  • Coloplast: Coloplast is a global leader in ostomy, continence, and pelvic floor products, including pessaries and related women's health devices sold through the same urogynecology and urology channels Cosm targets. Comparable in product category and customer base, with much larger scale and geographic reach.
  • Caldera Medical: Caldera Medical develops and markets medical devices for pelvic floor disorders, including mesh and biologic implants for stress urinary incontinence and prolapse. Directly comparable as a focused pelvic-floor device specialist selling to the same urogynecologist customer base.

Broad incumbents

  • Medtronic: Medtronic operates in pelvic floor disorders through its sacral neuromodulation (InterStim) and gastroenterology/urology franchises, competing for the same incontinence patients via a different mechanism (neuromodulation vs. mechanical pessary) and acting as a broad incumbent in the broader pelvic health category.
  • Hologic: Hologic is a large women's health company spanning diagnostics, surgical, and skeletal health products, with overlapping reach into the OB/GYN and urogynecology channels Cosm sells into. Comparable as a broad incumbent that could represent both a competitor and a strategic acquirer.
  • Boston Scientific: Boston Scientific has a sizable women's health and pelvic floor franchise (including the Solyx and Obtryx sling systems) and competes with Cosm indirectly for the same prolapse and incontinence patients, albeit via a broader surgical-portfolio approach rather than personalized pessaries.

Emerging players

  • Axonics: Axonics develops sacral neuromodulation systems for urge incontinence and overactive bladder, addressing an overlapping patient population to Cosm via an implantable device. Comparable as a focused, growth-stage pelvic-health device company that has scaled commercially and provides a relevant exit/comp benchmark.
  • Renovia: Renovia is a women's health startup developing digital therapeutics and connected devices (e.g., leva Pelvic Health System) for pelvic floor disorders. Comparable as a venture-backed, emerging pelvic-floor player pursuing a tech-enabled, non-surgical approach that overlaps Cosm's patient population.
  • Elidah (Elvie): Elvie markets connected pelvic-floor exercise devices (e.g., Elvie Trainer, Perifit) targeting the same pelvic-floor-disorder patient population Cosm addresses, but via a consumer-grade muscle-training modality rather than a personalized medical device. Comparable as a venture-backed women's health/femtech peer.

Others

  • Materialise: Materialise is a global leader in 3D printing for medical devices, including patient-specific implants and surgical guides. Comparable to Cosm as a 3D-printing medical technology company, though Materialise is a much larger contract-manufacturing and software platform rather than a direct pessary competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cosm Medical social profiles

Digital presence

Cosm Medical compliance and trust

Trust signal

Compliance10 records

Cosm Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cosm Medical leadership team

Management profile

Number of profiles

Profiles5 records

Cosm Medical funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cosm Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cosm Medical

What does Cosm Medical do?

Cosm Medical designs, manufactures, and sells Gynethotics — the world's first personalized pessaries for pelvic floor disorders (prolapse and incontinence) — made-to-measure via 3D printing of biocompatible silicone based on clinician measurements and AI-assisted medical imaging. The company also provides a Clinic App for clinicians to design, order, and manage devices and patient data, and a Patient App for symptom reporting, education, and progress tracking. Products are Health Canada licensed and FDA cleared and are sold primarily through urogynecology and pelvic health clinics in Canada with U.S. expansion underway.

Is Cosm Medical a public or private company?

Cosm Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cosm Medical founded?

Cosm Medical was founded in 2021. It employs 11 to 50 people.

Where is Cosm Medical based?

Cosm Medical is headquartered in Toronto, Canada, in the North America region.

How does Cosm Medical make money?

Two revenue lines are on record. Gynethotics Personalized Pessaries are the primary driver. The others are digital Gynecology Software Platforms.

Who are Cosm Medical's main competitors?

Direct peers on record are CooperSurgical, Coloplast and Caldera Medical. Broad incumbents are Medtronic, Hologic and Boston Scientific. Emerging players are Axonics, Renovia and Elidah (Elvie). Materialise is listed as an others.

Does Cosm Medical have an API?

No public API is recorded for Cosm Medical.

What industry is Cosm Medical in?

Cosm Medical's product category is Personalized Pelvic Health Medical Devices. Its primary akta.pro industry code is HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Financial PostCosm Medical Announces Licensing and Collaboration Agreement to Advance Post-Surgical Pelvic Recovery with Personalized Gynethotics™ DevicesCosm Medical Corp., a Toronto-based medical technology company, announced a licensing and collaboration agreement with Duke Health and Mayo Clinic to develop and commercialize Gynethotics™ Recovery, personalized intravaginal devices for post-surgical pelvic recovery following reconstructive surgery. Under the agreement, Cosm Medical has licensed intellectual property from both institutions related to a novel device design, with the collaboration focusing on product evaluation, clinical validation, and potential commercialization. The new product line builds on Cosm Medical's patented digital gynecology platform that integrates medical imaging and 3D-printing to deliver personalized biocompatible devices.The Canadian Press NewsCosm Medical Announces Licensing and Collaboration Agreement to Advance Post-Surgical Pelvic Recovery with Personalized Gynethotics™ DevicesCosm Medical announced a licensing and collaboration agreement with Duke Health and Mayo Clinic to develop personalized devices for post-surgical pelvic recovery. The partnership focuses on product evaluation, clinical validation, and commercialization of Gynethotics Recovery devices. Both institutions have financial interests in the technology.BioSpaceCosm Medical Announces Licensing and Collaboration Agreement to Advance Post-Surgical Pelvic Recovery with Personalized Gynethotics™ DevicesCosm Medical announced a licensing and collaboration agreement with Duke Health and Mayo Clinic to develop personalized intravaginal devices for post-surgical pelvic recovery. The partnership focuses on product evaluation, clinical validation, and commercialization, building on Cosm's patented digital gynecology platform.PR NewswireiGan Partners Leads Seed+ Financing for Cosm Medical to Advance Personalized Gynecological DevicesiGan Partners led a Seed+ financing round for Cosm Medical, a medical device company developing personalized gynecological devices. The round, including Spring Impact Capital and angels, will support U.S. expansion, clinical validation, and commercial growth. Cosm's Gynethotics platform combines imaging, AI, and 3D printing to create custom pessaries for pelvic floor disorders.YahooiGan Partners Leads Seed+ Financing for Cosm Medical to Advance Personalized Gynecological DevicesiGan Partners led a Seed+ financing round for Cosm Medical, a medical device company developing personalized gynecological devices for pelvic floor disorders. The round included Spring Impact Capital and several angels, supporting U.S. expansion, clinical validation, and commercial growth. Cosm's Gynethotics platform combines imaging, AI, and 3D printing to create custom pessaries.MorningstarCosm Medical Achieves FDA Clearance for Gynethotics™ Pessaries, Pioneering the future of personalized pelvic careCosm Medical received FDA clearance for Gynethotics pessaries, the first personalized pessary, following Health Canada clearance. The device offers nearly 10 million configurations versus about 100 from other pessaries, with a pilot study published in 2023. The company aims to impact over one million patients by 2030.YahooCosm Medical Achieves FDA Clearance for Gynethotics™ Pessaries, Pioneering the future of personalized pelvic careCosm Medical received FDA clearance for Gynethotics pessaries, the first personalized pessary, following Health Canada clearance. The device offers nearly 10 million configurations, compared to about 100 for other pessaries. The company aims to impact over one million patients by 2030.Business Wire BlogCosm Medical Achieves FDA Clearance for Gynethotics™ Pessaries, Pioneering the future of personalized pelvic careCosm Medical received FDA clearance for its Gynethotics pessaries, the first personalized pessary available to patients. The device offers nearly 10 million configurations, compared to about 100 from other pessaries, and a pilot study was published in 2023. The company aims to impact over one million patients by 2030.Business Wire BlogCosm Medical Achieves FDA Clearance for Gynethotics™ Pessaries, Pioneering the future of personalized pelvic careCosm Medical received FDA clearance for Gynethotics pessaries, the first personalized pessary available to patients. The device offers nearly 10 million configurations, compared to about 100 from other pessaries. The company aims to impact over one million patients by 2030.